Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Numerate Inc.
Headquarters: San Francisco, CA, United States of America
Website: N/A
Year Founded: 2007
Status: Acquired
BioCentury | Mar 10, 2021
Finance
David Berry’s Valo feeds its capital needs with $110M from new backer to build Opal
A $110 million venture infusion will enable Valo to build out its AI-based computational drug discovery and development platform and support its pipeline programs. The Koch Disruptive
BioCentury | Dec 22, 2020
Deals
Flagship’s Valo seeks cancer-like approach to CV drug development with G3 partnership
Valo and G3 go deep with an exclusive cardiometabolic “-omics” partnership
BioCentury | Sep 25, 2020
Product Development
Flagship’s Valo takes stab at cloud-based R&D with $96.5M and longitudinal human data
Flagship Pioneering is putting AI-accelerated drug development to the test with Valo Health LLC, whose cloud computing platform is geared to guide everything from target discovery to clinical trial
BioCentury | Jan 25, 2018
Strategy
Takeda rides Denali’s ATV
Denali deal reflects Takeda’s growing commitment to biologics for CNS disorders
BioCentury | Sep 14, 2017
Strategy
Numerate’s Intelligence
How Numerate’s AI tackles translational questions with tiny data sets
BioCentury | Sep 14, 2017
Strategy
Qrating assets
How Mayo and nference’s JV Qrativ plans to use AI to source and develop compounds
BioCentury | May 4, 2017
Tools & Techniques
Testing intelligence
Atomwise opens up its AI drug screening platform to partnerships, and skeptics
Items per page:
1 - 10 of 29